SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/B7D24C1FA6E9B1C3085DC724F8772F8F188D3373F8BBEA3D589ADC68026CC342B6358FE061DE19DBD9FF39BC4C426206>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/B7D24C1FA6E9B1C3085DC724F8772F8F188D3373F8BBEA3D589ADC68026CC342B6358FE061DE19DBD9FF39BC4C426206
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/B7D24C1FA6E9B1C3085DC724F8772F8F188D3373F8BBEA3D589ADC68026CC342B6358FE061DE19DBD9FF39BC4C426206
http://www.w3.org/2000/01/rdf-schema#comment
"Study provides evidence that PFKFB3 overexpression occupied a dominant position in sorafenib resistance of hepatocellular carcinoma cells."
xsd:string
http://purl.uniprot.org/uniprot/#_52DA7FDC861BC6077B2250119B21118EC02CFDE89E80D6256721A3924B171061429B49EA69956D8187D78CAA5C597BF4
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/B7D24C1FA6E9B1C3085DC724F8772F8F188D3373F8BBEA3D589ADC68026CC342B6358FE061DE19DBD9FF39BC4C426206
http://purl.uniprot.org/uniprot/Q9BQU1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B7D24C1FA6E9B1C3085DC724F8772F8F188D3373F8BBEA3D589ADC68026CC342B6358FE061DE19DBD9FF39BC4C426206
http://purl.uniprot.org/uniprot/#_Q9BQU1-mappedCitation-28857200
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B7D24C1FA6E9B1C3085DC724F8772F8F188D3373F8BBEA3D589ADC68026CC342B6358FE061DE19DBD9FF39BC4C426206